Proton-irradiated breast cells: molecular points of view

Autor: Valentina Bravatà 1, Francesco P. Cammarata 1, Luigi Minafra 1, Pietro Pisciotta 1, 2, Concetta Scazzone 3, Lorenzo Manti 4, Gaetano Savoca 1, Giada Petringa 1, Giuseppe A.P. Cirrone 2, Giacomo Cuttone 2, Maria C. Gilardi 1, 5, Giusi I. Forte 1, Giorgio Russo 1
Přispěvatelé: Bravata, V, Cammarata, F, Minafra, L, Pisciotta, P, Scazzone, C, Manti, L, Savoca, G, Petringa, G, Cirrone, G, Cuttone, G, Gilardi, M, Forte, G, Russo, G, Bravata, V., Cammarata, F. P., Minafra, L., Pisciotta, P., Scazzone, C., Manti, L., Savoca, G., Petringa, G., Cirrone, G. A. P., Cuttone, G., Gilardi, M. C., Forte, G. I., Russo, G., Bravatà, Valentina, Cammarata, Francesco P, Minafra, Luigi, Pisciotta, Pietro, Scazzone, Concetta, Manti, Lorenzo, Savoca, Gaetano, Petringa, Giada, Cirrone, Giuseppe A P, Cuttone, Giacomo, Gilardi, Maria C, Forte, Giusi I, Russo, Giorgio
Jazyk: angličtina
Rok vydání: 2019
Předmět:
breast cancer
cDNA microarray
gene signature
proton therapy
radiation
Breast
Breast Neoplasms
Cell Line
Tumor
DNA
Complementary
Dose-Response Relationship
Radiation
Female
Gene Expression Profiling
Gene Expression Regulation
Neoplastic
Humans
Inflammation
MCF-7 Cells
Oligonucleotide Array Sequence Analysis
Phenotype
Proton Therapy
Radiation Tolerance
Radiotherapy
Protons

DNA
Complementary

Health
Toxicology and Mutagenesis

medicine.medical_treatment
Breast Neoplasms
Cell fate determination
Radiation Tolerance
gene signature
03 medical and health sciences
0302 clinical medicine
Breast cancer
breast cancer
Cell Line
Tumor

Regular Paper
medicine
proton therapy
Humans
Radiology
Nuclear Medicine and imaging

Breast
Clonogenic assay
Biology
Proton therapy
Oligonucleotide Array Sequence Analysis
030304 developmental biology
Inflammation
cDNA microarray
0303 health sciences
Radiotherapy
Chemistry
Gene Expression Profiling
radiation
Cancer
Dose-Response Relationship
Radiation

Gene signature
medicine.disease
Gene Expression Regulation
Neoplastic

Gene expression profiling
Radiation therapy
Phenotype
030220 oncology & carcinogenesis
MCF-7 Cells
Cancer research
Female
Protons
Zdroj: Journal of radiation research 60 (2019): 451–465. doi:10.1093/jrr/rrz032
info:cnr-pdr/source/autori:Valentina Bravatà 1*, Francesco P. Cammarata 1*, Luigi Minafra 1,* Pietro Pisciotta 1,2, Concetta Scazzone 3, Lorenzo Manti 4, Gaetano Savoca 1, Giada Petringa 1,2, Giuseppe A.P. Cirrone 2, Giacomo Cuttone 2, Maria C. Gilardi 1,5, Giusi I. Forte 1 and Giorgio Russo 1/titolo:Proton-irradiated breast cells: molecular points of view./doi:10.1093%2Fjrr%2Frrz032/rivista:Journal of radiation research/anno:2019/pagina_da:451/pagina_a:465/intervallo_pagine:451–465/volume:60
Journal of Radiation Research
Popis: Breast cancer (BC) is the most common cancer in women, highly heterogeneous at both the clinical and molecular level. Radiation therapy (RT) represents an efficient modality to treat localized tumor in BC care, although the choice of a unique treatment plan for all BC patients, including RT, may not be the best option. Technological advances in RT are evolving with the use of charged particle beams (i.e. protons) which, due to a more localized delivery of the radiation dose, reduce the dose administered to the heart compared with conventional RT. However, few data regarding proton-induced molecular changes are currently available. The aim of this study was to investigate and describe the production of immunological molecules and gene expression profiles induced by proton irradiation. We performed Luminex assay and cDNA microarray analyses to study the biological processes activated following irradiation with proton beams, both in the non-tumorigenic MCF10A cell line and in two tumorigenic BC cell lines, MCF7 and MDA-MB-231. The immunological signatures were dose dependent in MCF10A and MCF7 cell lines, whereas MDA-MB-231 cells show a strong pro-inflammatory profile regardless of the dose delivered. Clonogenic assay revealed different surviving fractions according to the breast cell lines analyzed. We found the involvement of genes related to cell response to proton irradiation and reported specific cell line- and dose-dependent gene signatures, able to drive cell fate after radiation exposure. Our data could represent a useful tool to better understand the molecular mechanisms elicited by proton irradiation and to predict treatment outcome
Databáze: OpenAIRE